#GynCSM Transcript
Healthcare social media transcript of the #GynCSM hashtag.
– ().
See #GynCSM Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | Dee Sparacio @womenofteal RT @gyncsm: The #gyncsm (GYNecologic Cancer Social Media) chat will get started in a few minutes! You can read about tonight’s chat and preview the topic questions on our blog: https://t.co/ulXLaBbm5q |
 | GYN Cancer | #GYNCSM @gyncsm Welcome to #gyncsm - a passionate community for gynecologic cancer survivors, caregivers, advocates and health care providers. |
| Dee Sparacio @womenofteal RT @gyncsm: Welcome to #gyncsm - a passionate community for gynecologic cancer survivors, caregivers, advocates and health care providers. |
| GYN Cancer | #GYNCSM @gyncsm Our #gyncsm co-moderators are @womenofteal @btrfly12 Our health care advisors are @ShannonWestin @temkins @journeycancer and our mental health advisor @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. |
 | Christina Lizaso @btrfly12 Christina Lizaso – passionate re: community engagement and cancer care. I’ll be moderating as @gyncsm today. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Our #gyncsm co-moderators are @womenofteal @btrfly12 Our health care advisors are @ShannonWestin @temkins @journeycancer and our mental health advisor @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. |
| GYN Cancer | #GYNCSM @gyncsm If you prefer to “listen only” during the chat, we'd love for you to tweet "#gyncsm" when you join - just to let us know you are here. Please add along intro's and welcomes as I start in w/ the "ground rules" :) and tips! |
 | Tobey @BRCAinfo Hi #gyncsm Happy to join your tweet chat. |
 | Sevtap Savas, PhD @savaslab #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm The #gyncsm chat promotes community in a public forum. Chats are an open discussion and all are welcome to share from their experiences and perspectives. Learn more about risks/benefits: https://t.co/TipZUv1jQy |
| Sevtap Savas, PhD @savaslab RT @gyncsm: Welcome to #gyncsm - a passionate community for gynecologic cancer survivors, caregivers, advocates and health care providers. |
| Sevtap Savas, PhD @savaslab RT @gyncsm: New to tweetchats? Read tips from #gyncsm co-moderator @womenofteal https://t.co/m5bAfRjHVr |
| Sevtap Savas, PhD @savaslab RT @gyncsm: The #gyncsm chat promotes community in a public forum. Chats are an open discussion and all are welcome to share from their experiences and perspectives. Learn more about risks/benefits: https://t.co/TipZUv1jQy |
| GYN Cancer | #GYNCSM @gyncsm #gyncsm tagged resources and referrals are not a substitute for speaking with your doctor who understands your needs and history. |
| Sevtap Savas, PhD @savaslab RT @gyncsm: #gyncsm tagged resources and referrals are not a substitute for speaking with your doctor who understands your needs and history. |
| GYN Cancer | #GYNCSM @gyncsm Are you new to tweet chats? Follow hashtag #gyncsm under Explore - Latest and include the hashtag in every tweet during the next hour to engage with others about this topic. You may need to refresh to see new tweets as they are added. |
| Dee Sparacio @womenofteal Dee here. Ovarian cancer survivor , blogger, research advocate - joining you from Atlanta this month. Trying to get the wifi working so I can use my Ipad Oh #gyncsm co- moderator ,too |
| Christina Lizaso @btrfly12 RT @gyncsm: Are you new to tweet chats? Follow hashtag #gyncsm under Explore - Latest and include the hashtag in every tweet during the next hour to engage with others about this topic. You may need to refresh to see new tweets as they are added. |
| Dee Sparacio @womenofteal RT @gyncsm: If you prefer to “listen only” during the chat, we'd love for you to tweet "#gyncsm" when you join - just to let us know you are here. Please add along intro's and welcomes as I start in w/ the "ground rules" :) and tips! |
| Dee Sparacio @womenofteal RT @savaslab: #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Remember - Twitter is an open social network and posts are public. Use a Direct Message to exchange email addresses/personal information. #gyncsm |
| Dee Sparacio @womenofteal @BRCAinfo So happy to see you tonight- #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: The #gyncsm chat promotes community in a public forum. Chats are an open discussion and all are welcome to share from their experiences and perspectives. Learn more about risks/benefits: https://t.co/TipZUv1jQy |
| Dee Sparacio @womenofteal RT @gyncsm: #gyncsm tagged resources and referrals are not a substitute for speaking with your doctor who understands your needs and history. |
| Dee Sparacio @womenofteal RT @gyncsm: Are you new to tweet chats? Follow hashtag #gyncsm under Explore - Latest and include the hashtag in every tweet during the next hour to engage with others about this topic. You may need to refresh to see new tweets as they are added. |
| Sevtap Savas, PhD @savaslab RT @gyncsm: Remember - Twitter is an open social network and posts are public. Use a Direct Message to exchange email addresses/personal information. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Remember - Twitter is an open social network and posts are public. Use a Direct Message to exchange email addresses/personal information. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm We welcome all those joining in as well as those here to “listen in”. We'd love you to tweet #gyncsm so we know you are here and you can always tweet, DM or email us with questions/comments after the chat is over if you like. See our blog for info: https://t.co/oJ3xer7dY1 |
| Sevtap Savas, PhD @savaslab RT @gyncsm: We welcome all those joining in as well as those here to “listen in”. We'd love you to tweet #gyncsm so we know you are here and you can always tweet, DM or email us with questions/comments after the chat is over if you like. See our blog for info: https://t.co/oJ3xer7dY1 |
| GYN Cancer | #GYNCSM @gyncsm Thank you to all who have tweeted valuable information to our community during the past month using the #gyncsm hashtag and those who helped promote tonight's chat. |
 | Kathryn Pennington, MD @KPenningtonMD RT @SWOG: S2205 is a study about preventing a side effect of #chemotherapy called peripheral #neuropathy. It will test cooling and compression on the arms and legs during treatment. Learn more at https://t.co/qs8FRXyAM0. Or call 1-800-4-CANCER. Ask about S2205. #bcsm #lcsm #GynCSM #GICSM https://t.co/8YQHOGf6RJ |
| GYN Cancer | #GYNCSM @gyncsm Tonight on #gyncsm we’ll be discussing Gyn Cancer Research News from #SGOMtg and #ASCO23 You can find the Topic Questions we’ll cover on today’s chat on our blog: https://t.co/ulXLaBbm5q |
| Christina Lizaso @btrfly12 RT @gyncsm: Tonight on #gyncsm we’ll be discussing Gyn Cancer Research News from #SGOMtg and #ASCO23 You can find the Topic Questions we’ll cover on today’s chat on our blog: https://t.co/ulXLaBbm5q |
| GYN Cancer | #GYNCSM @gyncsm We’ll use a topic format with T1; T2 etc. Please include the corresponding T# at the front of your comment or answer. We will also end our chat with a chance to share TIL: thoughts standing for “Today I Learned”. #gyncsm |
| Sevtap Savas, PhD @savaslab RT @gyncsm: Tonight on #gyncsm we’ll be discussing Gyn Cancer Research News from #SGOMtg and #ASCO23 You can find the Topic Questions we’ll cover on today’s chat on our blog: https://t.co/ulXLaBbm5q |
| GYN Cancer | #GYNCSM @gyncsm T1: What #SGOMtg presentations did you find most interesting? #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Thank you to all who have tweeted valuable information to our community during the past month using the #gyncsm hashtag and those who helped promote tonight's chat. |
 | Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @gyncsm: Tonight on #gyncsm we’ll be discussing Gyn Cancer Research News from #SGOMtg and #ASCO23 You can find the Topic Questions we’ll cover on today’s chat on our blog: https://t.co/ulXLaBbm5q |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @gyncsm: We’ll use a topic format with T1; T2 etc. Please include the corresponding T# at the front of your comment or answer. We will also end our chat with a chance to share TIL: thoughts standing for “Today I Learned”. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Tonight on #gyncsm we’ll be discussing Gyn Cancer Research News from #SGOMtg and #ASCO23 You can find the Topic Questions we’ll cover on today’s chat on our blog: https://t.co/ulXLaBbm5q |
| Dee Sparacio @womenofteal RT @gyncsm: We’ll use a topic format with T1; T2 etc. Please include the corresponding T# at the front of your comment or answer. We will also end our chat with a chance to share TIL: thoughts standing for “Today I Learned”. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T1: T1: What #SGOMtg presentations did you find most interesting? #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @gyncsm: We welcome all those joining in as well as those here to “listen in”. We'd love you to tweet #gyncsm so we know you are here and you can always tweet, DM or email us with questions/comments after the chat is over if you like. See our blog for info: https://t.co/oJ3xer7dY1 |
| Christina Lizaso @btrfly12 With my #gyncsm co-moderator having internet connection issues, we may be a little slow going. Here is a news round up from #SGOMtg https://t.co/RYbC9YvL7w |
| Christina Lizaso @btrfly12 T1: I was glad to see a wide range of studies at this year's #SGOMtg with major studies for each of the three main gyn cancers but also studies for rarer types. #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian Non profit foundation, raising #ovariancancer awareness and research funds, and championing scientist - survivor collaboration. #gyncsm |
 | Sarah Cassidy @CassidyFish2 Looking forward to some great learnings! #gyncsm |
| Dee Sparacio @womenofteal I found the Pembrolizumab versus Placebo in Addition to Carboplatin and Paclitaxel for Measurable Stage 3 or 4a, Stage 4b or recurrent Endometrial Cancer : Phase 3 NRG GYO18 Study (Keynote 868) study extended survival most interesting. #gyncsm |
 | Elizabeth Hornsey @StRogista Interesting topics. #uterinecancer #wombcancer #endometrialcancer #gyncsm |
| Dee Sparacio @womenofteal I think I have the internet connection working now #gyncsm |
| Dee Sparacio @womenofteal Median Prog free survival 13 months Pembro versus 8 month survival #gyncsm |
| Dee Sparacio @womenofteal RT @StRogista: Interesting topics. #uterinecancer #wombcancer #endometrialcancer #gyncsm |
| Christina Lizaso @btrfly12 T1: So grateful for the advocates and healthcare providers that tweet from major conferences. You can check out the #SGOMtg feed to find pictures from slides shown at the meeting and links to learn more. #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @btrfly12: T1: T1: So grateful for the advocates and healthcare providers that tweet from major conferences. You can check out the #SGOMtg feed to find pictures from slides shown at the meeting and links to learn more. #gyncsm |
| Christina Lizaso @btrfly12 T1: Acronym buster: SGO = Society of Gynecologic Oncology #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: T1: T1: So grateful for the advocates and healthcare providers that tweet from major conferences. You can check out the #SGOMtg feed to find pictures from slides shown at the meeting and links to learn more. #gyncsm |
 | Megan Hutchcraft MD @MeganLeigh127 @SoMeCME @DrMMurphy How frequently do you monitor for irAE? 🤔 #gyncsm #endometrialcancer @RiosDoriaMD @LoganCoreyMD @gyoedu @BPothuri @ShannonWestin @amandanfader @StephanieVBlank @LAMcAlarnenMD @drteplinsky @drdonsdizon https://t.co/NcAeIf7aKm |
| Christina Lizaso @btrfly12 T1: @womenofteal also covered #SGOMtg on her blog https://t.co/D6OO3AscjC #gyncsm |
| Dee Sparacio @womenofteal There was also the Ruby Trial at #SGOmtg this tweet talks about both. https://t.co/8eCXA5tM8T #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @btrfly12: T1: T1: @womenofteal also covered #SGOMtg on her blog https://t.co/D6OO3AscjC #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm T2: Which #ASCO23 studies do you think may be of most interest to patients? #gyncsm |
| Tobey @BRCAinfo RT @btrfly12: T1: T1: So grateful for the advocates and healthcare providers that tweet from major conferences. You can check out the #SGOMtg feed to find pictures from slides shown at the meeting and links to learn more. #gyncsm |
| Dee Sparacio @womenofteal Immunotherapy trials seemed to be most talked about at #SGOmtg. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T2: T2: Which #ASCO23 studies do you think may be of most interest to patients? #gyncsm |
| Christina Lizaso @btrfly12 T2: I found this @CancerNetwrk Gyn Cancer round-up page highlighted the main #ASCO23 studies for #gyncsm https://t.co/On7JaMuguW |
| Dee Sparacio @womenofteal RT @btrfly12: T2: T2: I found this @CancerNetwrk Gyn Cancer round-up page highlighted the main #ASCO23 studies for #gyncsm https://t.co/On7JaMuguW |
| Christina Lizaso @btrfly12 T2: Acronym buster: ASCO = American Society of Clinical Oncology #gyncsm |
| Dee Sparacio @womenofteal The Shape trial for Cervical cancer: phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC) : fewer side effect w/ simple #gyncsm |
| Christina Lizaso @btrfly12 T2: Here's @womenofteal coverage of #ASCO23 https://t.co/w9fCx5QaHp #gyncsm |
| Elizabeth Hornsey @StRogista Highlights from #SGOMtg about #ovariancancer #endometrialcancer #wombcancer #uterinecancer #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @btrfly12: T2: T2: Here's @womenofteal coverage of #ASCO23 https://t.co/w9fCx5QaHp #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @btrfly12: T2: T2: I found this @CancerNetwrk Gyn Cancer round-up page highlighted the main #ASCO23 studies for #gyncsm https://t.co/On7JaMuguW |
| Dee Sparacio @womenofteal T2 Lots of discussions on Antibody drug conjugates at #ASCO23 #gyncsm https://t.co/RMHLetjz8v |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @womenofteal: Immunotherapy trials seemed to be most talked about at #SGOmtg. #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: T2: T2: Here's @womenofteal coverage of #ASCO23 https://t.co/w9fCx5QaHp #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm T3: In the last year, have there been any practice-changing gyn cancer studies patients should know about? (cervical, endometrial/uterine, ovarian. vaginal, vulvar, or other) #gyncsm |
| Megan Hutchcraft MD @MeganLeigh127 @SoMeCME @DrMMurphy Do you have any irAE management pearls for patients taking IO for #endometrialcancer? #gyncsm @Bhandoria @IJGConline @FBackesMD @ArendRebecca @BarbaraAGoff @ArchiMed24 @jscalici @Doctor_Beryl @bjdmatthews @RiosDoriaMD @TeresaBoitano @dholakiamd @delararitchie @uppals https://t.co/GmxrQd5PlG |
| Elizabeth Hornsey @StRogista #endometrialcancer #uterinecancer #wombcancer #gyncsm |
| Tobey @BRCAinfo I’m sorry that I have to jump off the chat. I’ll catch the transcript. Be well everyone 🌹🙏 #gyncsm |
| Elizabeth Hornsey @StRogista #endometrialcancer #uterinecancer #wombcancer #gyncsm |
| Dee Sparacio @womenofteal T2 eye toxicities with ADC’s can be handled with steroids. #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @womenofteal: T2 Lots of discussions on Antibody drug conjugates at #ASCO23 #gyncsm https://t.co/RMHLetjz8v |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @womenofteal: T2 eye toxicities with ADC’s can be handled with steroids. #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @gyncsm: T3: T3: In the last year, have there been any practice-changing gyn cancer studies patients should know about? (cervical, endometrial/uterine, ovarian. vaginal, vulvar, or other) #gyncsm |
| Christina Lizaso @btrfly12 T3: The Future of Endometrial Cancer Treatment Based on Practice-Changing SGO Abstracts https://t.co/28YwEdpOKw via @targetedonc #gyncsm |
| Christina Lizaso @btrfly12 T3: T-DXd May be ‘Practice Changing’ in HER2+ Gynecologic Cancers https://t.co/PrYeZruLbE via @CancerNetwrk #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T3: T3: In the last year, have there been any practice-changing gyn cancer studies patients should know about? (cervical, endometrial/uterine, ovarian. vaginal, vulvar, or other) #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: T3: T3: T-DXd May be ‘Practice Changing’ in HER2+ Gynecologic Cancers https://t.co/PrYeZruLbE via @CancerNetwrk #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: T3: T3: The Future of Endometrial Cancer Treatment Based on Practice-Changing SGO Abstracts https://t.co/28YwEdpOKw via @targetedonc #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian @womenofteal @BPothuri #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @btrfly12: T3: T3: T-DXd May be ‘Practice Changing’ in HER2+ Gynecologic Cancers https://t.co/PrYeZruLbE via @CancerNetwrk #gyncsm |
| Elizabeth Hornsey @StRogista #endometrialcancer #uterinecancer #wombcancer #gyncsm |
| Dee Sparacio @womenofteal T3 Cervical Cancer OS from Keynote 826 #gyncsm https://t.co/WmHASBHvJP |
| GYN Cancer | #GYNCSM @gyncsm T4: What are some of the "hot topics" in gynecologic cancer research currently? #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T4: T4: What are some of the "hot topics" in gynecologic cancer research currently? #gyncsm |
| Dee Sparacio @womenofteal T4 For me From what was reported at SGO/ASCO antibody drug conjugates and immunotherapies were the hot topics. #gyncsm |
| Christina Lizaso @btrfly12 T4: It feels like we've been talking about targeted therapies and immunotherapy for years, but research is a long game and there are more studies each year on applying these newer modalities to gyn cancers. Here's to these staying on the hot topic list #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: T4: T4: It feels like we've been talking about targeted therapies and immunotherapy for years, but research is a long game and there are more studies each year on applying these newer modalities to gyn cancers. Here's to these staying on the hot topic list #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @btrfly12: T4: T4: It feels like we've been talking about targeted therapies and immunotherapy for years, but research is a long game and there are more studies each year on applying these newer modalities to gyn cancers. Here's to these staying on the hot topic list #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @womenofteal: T4 For me From what was reported at SGO/ASCO antibody drug conjugates and immunotherapies were the hot topics. #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @gyncsm: T4: T4: What are some of the "hot topics" in gynecologic cancer research currently? #gyncsm |
| Christina Lizaso @btrfly12 #gyncsm Cancer Glossary via @theNCI antibody-drug conjugate https://t.co/0y60ZFPJPr |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @btrfly12: #gyncsm Cancer Glossary via @theNCI antibody-drug conjugate https://t.co/0y60ZFPJPr |
| GYN Cancer | #GYNCSM @gyncsm T5: Both #ASCO23 and #SGOmtg held sessions on disparity and equity in cancer care. What was highlighted and how can we work to decrease disparities in gynecologic cancer care? #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian @gyncsm We can point out all the voices that are missing from conversations. #gyncsm |
| Dee Sparacio @womenofteal T4 The best practices for PARP use in OC is an important discussion too. #gyncsm https://t.co/63fMN2PXta |
| Dee Sparacio @womenofteal RT @gyncsm: T5: T5: Both #ASCO23 and #SGOmtg held sessions on disparity and equity in cancer care. What was highlighted and how can we work to decrease disparities in gynecologic cancer care? #gyncsm |
| Christina Lizaso @btrfly12 T5: It also feels like we've been talking about disparity and equity for years, but I do see more and more studies taking deep dives and it is great to see gyn-specific studies that are fully about disparities or at least have incorporated it into the research. #gyncsm |
| Christina Lizaso @btrfly12 Yes. We all need to focus and speak up. We need to work to keep this central to the conversation. #gyncsm |
| Christina Lizaso @btrfly12 T5: Disparity and Equity are complicated to study, but it is entirely possible to not only study but design practical interventions to address. It can seem daunting but when we include more voices we can go far. #gyncsm |
| Dee Sparacio @womenofteal T5 Should we treat Pacific Islanders the same as Asian population.?#gyncsm https://t.co/yXGOSYqVRb |
| GYN Cancer | #GYNCSM @gyncsm T6: Cancer drug shortages were highlighted at both #SGOMtg and #ASCO23. What resources for health care providers and patients are available? #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: Yes. We all need to focus and speak up. We need to work to keep this central to the conversation. #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: T5: T5: Disparity and Equity are complicated to study, but it is entirely possible to not only study but design practical interventions to address. It can seem daunting but when we include more voices we can go far. #gyncsm |
| Christina Lizaso @btrfly12 RT @gyncsm: T6: T6: Cancer drug shortages were highlighted at both #SGOMtg and #ASCO23. What resources for health care providers and patients are available? #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T6: T6: Cancer drug shortages were highlighted at both #SGOMtg and #ASCO23. What resources for health care providers and patients are available? #gyncsm |
| Christina Lizaso @btrfly12 T4: #gyncsm hot topic: Radical hysterectomy and Cervical cancer: SHAPE Trial https://t.co/h7nMxxKdDZ |
| Dee Sparacio @womenofteal T6 @SGO_org has been working hard to highlight the impact of shortages on patients with the Congress and the public #gyncsm https://t.co/fpSPfY7dHA |
| Dee Sparacio @womenofteal RT @btrfly12: T4: T4: #gyncsm hot topic: Radical hysterectomy and Cervical cancer: SHAPE Trial https://t.co/h7nMxxKdDZ |
| Christina Lizaso @btrfly12 #gyncsm - there was also a gyn cancer study highlighted at @AACR American Association for Cancer Research Predicting Risk of Distant Recurrence in Endometrial Cancer https://t.co/WPMTu1NrrY |
| Christina Lizaso @btrfly12 RT @womenofteal: T6 @SGO_org has been working hard to highlight the impact of shortages on patients with the Congress and the public #gyncsm https://t.co/fpSPfY7dHA |
| Christina Lizaso @btrfly12 T6: @ASCO Drug Shortages Resource Page https://t.co/278a5DQvMr #gyncsm |
| Dee Sparacio @womenofteal T1 @Stigetta did an excellent job highlighting SGO mtg research #gyncsm https://t.co/xmn0f385CK |
| Dee Sparacio @womenofteal RT @btrfly12: #gyncsm - there was also a gyn cancer study highlighted at @AACR American Association for Cancer Research Predicting Risk of Distant Recurrence in Endometrial Cancer https://t.co/WPMTu1NrrY |
| GYN Cancer | #GYNCSM @gyncsm Thanks all who joined along. We use the last few minutes of the chat to wrap up and share with each other what you learned or were reminded of during this chat. You can start your tweet with TIL: standing for “Today I Learned”. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Note there is no #gyncsm chat in August. Stay tuned for information about our next chat which will be held in September during Gynecologic Cancer Awareness Month / Ovarian Cancer Awareness Month. |
| Dee Sparacio @womenofteal RT @gyncsm: Thanks all who joined along. We use the last few minutes of the chat to wrap up and share with each other what you learned or were reminded of during this chat. You can start your tweet with TIL: standing for “Today I Learned”. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Note there is no #gyncsm chat in August. Stay tuned for information about our next chat which will be held in September during Gynecologic Cancer Awareness Month / Ovarian Cancer Awareness Month. |
| GYN Cancer | #GYNCSM @gyncsm Feel free to keep answering tonight's topic questions if you are just joining or reading later :) Just include hashtag #gyncsm in your response tweets. |
| GYN Cancer | #GYNCSM @gyncsm As always, remember to tweet things of interest with hashtag #gyncsm to keep the conversation going between chats. |
| GYN Cancer | #GYNCSM @gyncsm Grateful for our #gyncsm moderators/advisors! @btrfly12 @ShannonWestin @temkins @journeycancer @DrBeckerSchutte #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm We'll post the transcript from tonight's chat and then a blog post with a summary. You can look for that in the #gyncsm feed or pinned to our profile. Thanks @womenofteal for all your work on the blog. We also have our 2023 chat dates posted there. https://t.co/oJ3xer6G8t |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @gyncsm: We'll post the transcript from tonight's chat and then a blog post with a summary. You can look for that in the #gyncsm feed or pinned to our profile. Thanks @womenofteal for all your work on the blog. We also have our 2023 chat dates posted there. https://t.co/oJ3xer6G8t |
| Christina Lizaso @btrfly12 RT @power4patients: What #ovariancancer risk factors should patients know about? @drebonyhoskins of @MedStarWHC shares common risk factors and patient advice. https://t.co/2QW9iR6aNe #gyncsm |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @gyncsm: Note there is no #gyncsm chat in August. Stay tuned for information about our next chat which will be held in September during Gynecologic Cancer Awareness Month / Ovarian Cancer Awareness Month. |
| Christina Lizaso @btrfly12 RT @gyncsm: Feel free to keep answering tonight's topic questions if you are just joining or reading later :) Just include hashtag #gyncsm in your response tweets. |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @gyncsm: Feel free to keep answering tonight's topic questions if you are just joining or reading later :) Just include hashtag #gyncsm in your response tweets. |
| Christina Lizaso @btrfly12 RT @gyncsm: Note there is no #gyncsm chat in August. Stay tuned for information about our next chat which will be held in September during Gynecologic Cancer Awareness Month / Ovarian Cancer Awareness Month. |
| Dee Sparacio @womenofteal Grateful for all those who joined us tonight! And for all those who Tweet using the #gyncsm hashtag during the month. Thanks @btrfly12 for doing so much during this chat as I’ve been busy with helping family move And away from Twitter / the internet for the past few days. |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @womenofteal: T1 @Stigetta did an excellent job highlighting SGO mtg research #gyncsm https://t.co/xmn0f385CK |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @btrfly12: T6: T6: @ASCO Drug Shortages Resource Page https://t.co/278a5DQvMr #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Grateful for our #gyncsm moderators/advisors! @btrfly12 @ShannonWestin @temkins @journeycancer @DrBeckerSchutte #gyncsm |
| Christina Lizaso @btrfly12 #gyncsm TIL: about addressing eye toxicities: |
| Dee Sparacio @womenofteal Been a bit of a challenge working on an iPad and phone this chat. I miss my laptop! #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: We'll post the transcript from tonight's chat and then a blog post with a summary. You can look for that in the #gyncsm feed or pinned to our profile. Thanks @womenofteal for all your work on the blog. We also have our 2023 chat dates posted there. https://t.co/oJ3xer6G8t |
| Powell-Drescher Ovarian Cancer Research Foundation @PowerOvarian RT @womenofteal: T6 @SGO_org has been working hard to highlight the impact of shortages on patients with the Congress and the public #gyncsm https://t.co/fpSPfY7dHA |
| Dee Sparacio @womenofteal RT @btrfly12: #gyncsm TIL: #gyncsm TIL: about addressing eye toxicities: |
 | NCI Cancer Stats @NCICancerStats New #OvarianCancer cases are diagnosed most often in women between 55-74 years. The median age of diagnosis is 63. Visit our Cancer Stat Facts sheet to learn more: https://t.co/HWrp6HOzTG #GynCSM https://t.co/kueNmokDxx |
#GynCSM content from Twitter.